BRG.AU

27.59

+2.3%↑

BRG.AU

27.59

+2.3%↑

BRG.AU

27.59

+2.3%↑

BRG.AU

27.59

+2.3%↑

BRG.AU

27.59

+2.3%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Closed

SectorReal estate

31.61 1.67

Overview

Share price change

24h

Current

Min

31.36

Max

31.7

Key metrics

By Trading Economics

Income

153M

Sales

951M

P/E

Sector Avg

147.238

75.046

EPS

0.26

Dividend yield

1.22

Profit margin

16.106

Employees

6,978

EBITDA

276M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.95% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.22%

6.10%

Next Earnings

28 May 2025

Market Stats

By TradingEconomics

Market Cap

-3.9B

18B

Previous open

29.94

Previous close

31.61

Fisher & Paykel Healthcare Corp Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

8 Apr 2025, 02:01 UTC

Market Talk

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 Feb 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 Feb 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 Nov 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 Nov 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 Sept 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 May 2024, 00:44 UTC

Market Talk
Earnings

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 May 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 May 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 May 2024, 20:59 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 May 2024, 20:58 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 May 2024, 20:57 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 May 2024, 20:56 UTC

Earnings

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

Peer Comparison

Price change

Fisher & Paykel Healthcare Corp Ltd Forecast

Price Target

By TipRanks

20.95% upside

12 Months Forecast

Average 37.64 AUD  20.95%

High 42.1 AUD

Low 35 AUD

Based on 6 Wall Street analysts offering 12 month price targets forFisher & Paykel Healthcare Corp Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

2

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.